Gold Fields to Buy Canada’s Yamana for About $7 Billion

image

(Bloomberg) — Gold Fields Ltd. agreed to buy Canada’s Yamana Gold Inc. for about $7 billion in shares as the South African miner expands in the Americas.

Johannesburg-based Gold Fields will offer 0.6 of one of its shares for each Yamana share, the company said in a statement. Based on the ten-day volume weighted average traded price of Gold Fields’ American depositary shares, the deal would imply a 34% premium to Yamana’s closing share price on May 27, the company said.

Yamana has mines in Canada, Argentina, Chile and Brazil, and Gold Fields said the deal fits with its strategy of expanding in “mining friendly” jurisdictions across the Americas. The South African company founded by Cecil Rhodes in 1887 has shifted focus in recent years to more lucrative mines in Ghana, Australia and Latin America as producers in its home country struggle with power cuts, soaring costs and the geological challenges of exploiting the world’s deepest deposits.

“The result is a combination with much greater capacity and potential value than the sum of its parts,” Gold Fields Chief Executive Officer Chris Griffith said in the statement.

The tie-up is the latest in a revived shift toward consolidation in the gold industry over the past year. Newcrest Mining Ltd. agreed in November to buy Pretium Resources Inc. in a cash and shares deal valuing the Canadian gold producer at about $2.8 billion, while in September, Agnico Eagle Mines Ltd. and Kirkland Lake Gold Ltd. announced a “merger of equals” valued at about C$13.4 billion.

Yamana’s board has agreed to back the deal, which will require approval from both sets of shareholders and is expected to close in the second half of the year. Gold Fields shareholders would own about 61% of the combined company, Yamana investors would hold 39%, and the company will remain headquartered in Johannesburg.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More